US 10472376
Amide compound
granted A61PA61P1/04A61P17/06
Quick answer
US patent 10472376 (Amide compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/04, A61P17/06, A61P19/02, A61P25/00